Добавил:
kiopkiopkiop18@yandex.ru Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

3 курс / Фармакология / Диссертация_Гайдукова_К_А_Антитромбогенная_активность_новых_производных

.pdf
Скачиваний:
0
Добавлен:
24.03.2024
Размер:
3.22 Mб
Скачать

 

 

191

 

214.

Wu

L.T., Jiang Z., Shen J.J., Yi H.

Design, synthesis and biological

evaluation

of

novel benzimidazole-2-substituted

phenyl or pyridine propyl

ketene derivatives as antitumour agents // Eur J Med Chem.- 2016.- 114.-

P. -328-336.

215. Xiang Q., Pang X., Liu Z., Yang G., Progress in the

development

of antiplatelet agents: Focus on the targeted molecular pathway from bench to clinic //

Pharmacol

Ther.- 2019.-26.-P. 1-6

 

 

 

 

 

216.

Xie

Z., Tian

Y., Ma

L., Lv

X.

Developments

in

inhibiting platelet aggregation based on different design strategies // Future Med Chem.- 2019.-11(14).-P. 1757-1775.

217.Yamamoto J., Inoue N. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential//Thrombosis Research.-2014.-133.-P. 919-926

218.Yang P.S., Pak H.N., Park D.H., Yoo J. et al. Non-cardioembolic risk factors in atrial fibrillation-associated ischemic stroke // PLoS One.- 2018.- 20;13(7).-P. 10-22.

219.

Ye

T.,

Shi H.,

Phan-Thien

N.,

Lim C.T.

The

key

events

of thrombus formation:

platelet

adhesion

and

aggregation//

Biomech

Model

Mechanobiol.- 2019.-21.-P.1-12.

 

 

 

 

 

 

220.

Yeo

K.K., Armstrong E.J., López

J.E., Chen D.C., et

al.

Aspirin

and clopidogrel high on-treatment platelet reactivity and genetic predictors in peripheral arterial disease// Catheter Cardiovasc Interv.- 2018.-91(7).-P.-1308-1317.

221.Yusuf S., McKee M. Documenting the global burden of cardiovascular disease: a major achievement but still a work in progress//Circulation. -2014.-129(14).- P.1459-1462.

222.Zhao S., Li Z., Huang F., Wu J., et al. Nano-scaled MTCA-KKV: for

targeting

thrombus,

releasing

pharmacophores, inhibiting thrombosis

and

dissolving blood clots in vivo// Int J Nanomedicine.-2019.-14.-P. 4817-4831.

 

223.

Zhao

B.W., Zhang

X.H., Gu

Y., Zhao

S., et

al.

Anti-

platelet aggregation mechanism of Xixian Tongshuan Preparation based on molecular simulation methods// Zhongguo Zhong Yao Za Zhi.-2019.- 44(9).-P. 1882-1888.

Соседние файлы в папке Фармакология